Touyun Biotech Group (HKSE:01332) 5-Year EBITDA Growth Rate : 0.50% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Touyun Biotech Group 5-Year EBITDA Growth Rate?

Touyun Biotech Group's EBITDA per Share for the six months ended in Dec. 2023 was HK$-0.07.

During the past 3 years, the average EBITDA Per Share Growth Rate was -24.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 0.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Touyun Biotech Group was 100.90% per year. The lowest was -31.40% per year. And the median was 23.80% per year.

Competitive Comparison of Touyun Biotech Group's 5-Year EBITDA Growth Rate

For the Packaging & Containers subindustry, Touyun Biotech Group's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Touyun Biotech Group's 5-Year EBITDA Growth Rate Distribution in the Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Touyun Biotech Group's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Touyun Biotech Group's 5-Year EBITDA Growth Rate falls into.

Touyun Biotech Group 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Touyun Biotech Group (HKSE:01332) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Touyun Biotech Group 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Touyun Biotech Group's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Touyun Biotech Group (HKSE:01332) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Touyun Biotech Group Ltd (HKSE:01332) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Tonnochy Road, 12th Floor, Kwan Chart Tower, Wanchai, Hong Kong, HKG

Website

https://www.touyunbiotech.com.hk

Touyun Biotech Group Ltd, formerly China Touyun Tech Group Ltd, an investment holding company, designs, develops, manufactures, and sells packaging products and point-of-sales display units. It operates with four business segments, Packaging Products, Treasury Investment, QR code business, and Chlamydomonas reinhardtii product business. Through the Packaging Products segment, it offers watch boxes, jewelry boxes, eyewear cases, bags and pouches, and display units whereas the Treasury segment engages in the trading of securities and money lending activities. It derives a majority of its revenue from the Packaging products. The business activity of the group is operated in Hong Kong, Mainland China, North and South America, and other countries.

Executives

Wang Liang	2101 Beneficial owner
Tian Yuze	2101 Beneficial owner
Tian Yuze	2101 Beneficial owner
Qiao Yanfeng	2201 Interest of corporation controlled by you
Qin Fen	2101 Beneficial owner

Touyun Biotech Group (HKSE:01332) Headlines

No Headlines